Ultime notizie per Rite Aid Corp (OTC:RADCQ) Azioni

Rite Aid Corp

News

Guidance

CVS's Q3 Results Won't Meet Wall Street's Expectations; Plans To Back Away From Current 2024 Guidance

<p>HC Wainwright &amp; Co.  analyst Heiko Ihle   reiterates DRDGold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRD#NYSE">DRD</a>) with a Buy and maintains $13.25 price target.</p>


Price Target

Reiteration

Analyst Ratings

HC Wainwright & Co. Reiterates Buy on DRDGold, Maintains $13.25 Price Target

Management

CVS Naming Caremark President David Joyner As Its New CEO

<p>HC Wainwright &amp; Co.  analyst Heiko Ihle   reiterates Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) with a Buy and maintains $1.5 price target.</p>


HC Wainwright & Co. Reiterates Buy on Avino Silver & Gold Mines, Maintains $1.5 Price Target

Biotech

Large Cap

Health Care

General

The European Medicines Agency's Committee For Medicinal Products For Human Use Has Adopted A Positive Opinion, Recommending Approval Of Novo Nordisk's Alhemo (Concizumab) As The First Once-Daily Subcutaneous Prophylactic Treatment For People Aged 12 Years Or Older With Hemophilia A Or B With Inhibitors.

<p>HC Wainwright &amp; Co.  analyst Heiko Ihle   reiterates First Majestic Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AG#NYSE">AG</a>) with a Buy and maintains $8.5 price target.</p>


HC Wainwright & Co. Reiterates Buy on First Majestic Silver, Maintains $8.5 Price Target

<p>The combined companies for the trailing twelve months have generated $235 million in revenue, increasing approximately&nbsp;25%&nbsp;quarter-over-quarter.</p>


BTTR

Better Choice Expects Combined 2025 Pro Forma Basis Revenue And EBITDA To Be Approximately +$270M, And +$10M, Respectively

Better Choice Says Continues To Make Progress Towards Closing Of Its Acquisition Of SRx Health Solutions; Expects Transaction To Close In Late Q4 Of This Year Or Early Q1 Of 2025

<p>Needham  analyst Ami Fadia   reiterates Neumora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRA#NASDAQ">NMRA</a>) with a Buy and maintains $23 price target.</p>


NMRA

Needham Reiterates Buy on Neumora Therapeutics, Maintains $23 Price Target

<p>Based on sales trends and order intake in recent years, it expects further market share gains with domestic Chinese OEMs in the coming years.</p>
<p>With the seasonally strong fourth quarter remaining of the year, it reaffirms&nbsp;guidance of around 9.5-10.0% adjusted operating margin for 2024, but to be at the low end of this range.</p>
<p>&nbsp;</p>


Autoliv Now Expects Full Year 2024 Organic Sales Growth To Be 1% Instead Of Previously Expected 2% Due To Unfavorable Market Mix Development

<p>Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.53 by 7.55 percent. This is a 16.33 percent increase over earnings of $0.49 per share from the same period last year.  The company reported quarterly sales of $1.87 billion which beat the analyst consensus estimate of $1.80 billion by 3.78 percent.  This is a 0.54 percent increase over sales of $1.86 billion the same period last year.</p>


Earnings

Earnings Beats

Regions Finl Q3 Adj $0.57 Beats $0.53 Estimate, Sales $1.87B Beat $1.80B Estimate

<p>HC Wainwright &amp; Co.  analyst Patrick Trucchio   reiterates Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and maintains $400 price target.</p>


ALNY

HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $400 Price Target

<p>Autoliv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) reported quarterly earnings of $1.84 per share which missed the analyst consensus estimate of $1.95 by 5.64 percent.  The company reported quarterly sales of $2.56 billion which beat the analyst consensus estimate of $2.53 billion by 0.89 percent.  This is a 1.58 percent decrease over sales of $2.60 billion the same period last year.</p>


Earnings Misses

Autoliv Q3 2024 Adj EPS $1.84 Misses $1.95 Estimate, Sales $2.56B Beat $2.53B Estimate

<p>HC Wainwright &amp; Co.  analyst Amit Dayal   reiterates Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) with a Buy and maintains $14 price target.</p>


GEVO

HC Wainwright & Co. Reiterates Buy on Gevo, Maintains $14 Price Target

<p>Needham  analyst Ami Fadia   reiterates Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) with a Buy and maintains $22 price target.</p>


Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

<p>Needham  analyst Mayank Tandon   maintains WNS (Hldgs) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) with a Buy and lowers the price target from $70 to $60.</p>


Needham Maintains Buy on WNS (Hldgs), Lowers Price Target to $60

<p>Needham  analyst Kyle Peterson   reiterates Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and maintains $350 price target.</p>


Needham Reiterates Buy on Equifax, Maintains $350 Price Target

<p>Needham  analyst Mike Matson   downgrades Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) from Buy to Hold and maintains the price target from $86 to $86.</p>


Downgrades

Needham Downgrades Boston Scientific to Hold, Maintains Price Target to $86

<p><a href="https://www.reuters.com/technology/apples-new-iphone-sales-china-jump-20-first-3-weeks-counterpoint-says-2024-10-18/" title="https://www.reuters.com/technology/apples-new-iphone-sales-china-jump-20-first-3-weeks-counterpoint-says-2024-10-18/">https://www.reuters.com/technology/apples-new-iphone-sales-china-jump-20-first-3-weeks-counterpoint-says-2024-10-18/</a></p>


Tech

AAPL

Reported Earlier, Apple's New iPhone Sales In China Rose 20% In First 3 Weeks

<p>EV <a href="https://www.benzinga.com/news/24/10/41223011/rivians-production-guidance-cut-spurred-by-miscommunication-with-atlanta-based-supplier-resulting-in">startup</a> <strong>Rivian Automotive</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) said on Thursday that it will launch its Halloween software update starting Oct. 18, complete with spooky features and car costumes.</p>
<p><strong>What Happened: </strong>The company announced the update in a video posted on social media platform X featuring actor <strong>David Hasselhoff </strong>who starred in the Knight Rider series.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">An iconic duo reunited <a href="https://twitter.com/DavidHasselhoff?ref_src=twsrc%5Etfw">@DavidHasselhoff</a>.⁰<br /><br />The countdown is on. Our Halloween software update arrives after the clock strikes midnight (local). Spooky features will be available for a limited time. <a href="https://t.co/hdKV0z4WIC">pic.twitter.com/hdKV0z4WIC</a></p>
<p>&mdash; Rivian (@Rivian) <a href="https://twitter.com/Rivian/status/1846945663860572411?ref_src=twsrc%5Etfw">October 17, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>One of the car costumes available with the update is inspired by Knight Rider. The costume will alter the Rivian&#8217;s interior display system and the exterior lightbar on Gen 2 R1 vehicles will cascade a red beam to replicate the experience of K.I.T.T, the robotic automobile that featured in the series.</p>
<p>There are also other car costumes available with the update, inspired by iconic and classic vehicles from pop culture, such as one inspired by the time machine in Universal Pictures and Amblin Entertainment's Back to the Future, in addition to a spooky option. </p>
<p>The haunted Rivian car costume has eight different sound effects and three different color themes to choose from ranging between purple, yellow, red, and green. The interior display screen will feature static and ghosts to increase the spooky feeling when the vehicle is parked with the costume. </p>
<p><strong>Besides Costumes: </strong>Besides costumes, Rivian&#8217;s new update changes pedestrians on the driver display to zombies and bicyclists and motorcyclists into headless horsemen. </p>
<p>Vehicle owners can also play multiple spooky chirp sounds, including one resembling the owl. </p>
<p>However, the spooky features will only be available for a limited time until November 4, the company warned. Additionally, <a href="https://www.benzinga.com/news/24/08/40574576/rivian-or-lucid-which-of-the-two-loss-making-ev-startups-is-solving-cash-burn">both the vehicle</a> and the Rivian mobile app must be updated to their latest versions for the features, it added.</p>
<p><em>Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;</em><a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener"><em>following this link</em></a>.</p>
<p><strong>Read More:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/24/10/41324450/elon-musk-says-spacexs-next-generation-starlink-satellites-will-be-so-big-that-only-starship-can-lau" target="_blank" rel="noreferrer noopener">Elon Musk Says SpaceX's Next-Generation Starlink Satellites Will Be ‘So Big That Only Starship Can Launch Them'</a></strong></li>
</ul>
<p><em>Photo courtesy: Rivian</em></p>


RIVN

Trick Or Treat: Rivian Rolls Out Spooky Halloween Update Featuring Car Costumes, Creepy Chirps

Walgreens Plummets: Avoid At All Costs

Wall Street Lunch: Tough Road Ahead For Walgreens?

Rite Aid bankruptcy bid approved by court

Rite Aid to pay $101M to settle alleged false Medicare rebates

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>When it comes to cyber threats, we&rsquo;re sitting ducks. Our government, cities, major corporations, schools, hospitals, and even millions of individuals are still poorly prepared for more attacks. All of which is creating big opportunities for leading <a href="https://investorplace.com/industries/technology/cybersecurity/">cybersecurity stocks</a>. </p>



<p><strong>AT&amp;T</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/t-stock-quote/"><strong>T</strong></a>) just said nearly all of its <a href="https://www.washingtonpost.com/technology/2024/07/12/att-data-breach-hack-calls-texts-what-do/">wireless subscribers&rsquo; call and text interactions</a> were exposed in a massive hack in April. Auto dealerships just <a href="https://www.autonews.com/dealers/dealers-lost-102b-cdk-cyberattack-revised-aeg-study-says#">lost about $1.02 billion</a> in business after the CDK cyberattack.&nbsp;</p>



<p>Even <strong>Rite Aid</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/radcq-stock-quote/"><strong>RADCQ</strong></a>) just confirmed it was hacked, with the <a href="https://www.techradar.com/pro/security/rite-aid-confirms-data-breach-following-ransomware-attack#:~:text=%22While%20having%20access%20to%20the,on%20its%20dark%20web%20page.">cybercriminals noting</a>:<strong>&nbsp;</strong>&ldquo;While having access to the Rite Aid network we obtained over 10 GB of customer information equating to around 45 million lines of people&rsquo;s personal information. This information includes name, address, dl_id number, dob, and Riteaid rewards number.&rdquo;</p>



<p>Worse, <a href="https://www.usatoday.com/money/blueprint/business/vpn/cybersecurity-statistics/">according to a Cybersecurity Ventures report</a>, &ldquo;the cost of cybercrime hit $8 trillion in 2023 &mdash; translating to over $250,000 per second.&nbsp;The total annual cost is projected to rise to $10.5 trillion by 2025,&rdquo; as noted by USA Today. </p>



<p>The only positive is that with every major cyberattack, cybersecurity stocks get a boost, including:</p>



<h2><strong>Palo Alto Networks (PANW)</strong></h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/panw-stock-1-300x169.jpg" alt="Palo Alto Networks (PANW) logo on corporate building"><div>Source: Sundry Photography / Shutterstock.com</div></div><p>When I mentioned <strong>Palo Alto Networks</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/panw-stock-quote/"><strong>PANW</strong></a>) <a href="https://investorplace.com/2024/06/the-3-most-undervalued-cybersecurity-stocks-to-buy-in-june-2024/">on June 6</a>, I said, &ldquo;Over the last few months,&nbsp;PANW&nbsp;ran from $265 to $320. Now back to $290, I&rsquo;d again use weakness as an opportunity.&rdquo; Now up to $343, PANW &mdash; one of the top cybersecurity stocks to own &mdash; is still a strong buy.</p>



<p>Helping, analysts at <a href="https://seekingalpha.com/news/4118001-palo-alto-networks-rises-as-da-davidson-starts-with-buy-rating">D.A. Davidson recently initiated a buy</a> rating on the stock, with a price target of $380. Better, <a href="https://www.investing.com/news/company-news/palo-alto-networks-stock-target-raised-keeps-outperform-on-steady-demand-93CH-3499606">Baird has an outperform rating on the stock</a>, with a price target of $360.&nbsp;Plus, earnings have been solid.</p>



<p>In its third quarter, its earnings per share of $1.23 beat by seven cents. Revenue of $1.98 billion &mdash; up 15.1% year over year &mdash; beat by $10 million.&nbsp;Moving forward, the company expects&nbsp;<a href="https://www.streetinsider.com/Corporate+News/Palo+Alto+Networks+%28PANW%29+stock+drops+9%25+as+billings+outlook+disappoints/23252555.html#:~:text=However%2C%20the%20billings%20outlook%20for,slightly%20short%20of%20analysts'%20expectations.">fourth-quarter billings to range from $3.43 billion to $3.48 billion</a>, which is a year-over-year growth range of 9% to 10%. It also expects to see total revenue of $2.15 billion to $2.17 billion, as compared to estimates of $2.16 billion.&nbsp;</p>



<h2><strong>Zscaler (ZS)</strong></h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/05/zs-stock-300x169.jpg" alt="Zscaler (ZS) logo on a corporate building"><div>Source: Sundry Photography / Shutterstock.com</div></div><p>On June 6, I also mentioned opportunity in <strong>Zscaler</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/zs-stock-quote/"><strong>ZS</strong></a>), noting, &ldquo;With negativity now&nbsp;priced in, I&rsquo;d use the weakness as an opportunity to buy the stock.&rdquo;</p>



<p>At the time, ZS traded at about $174. Today, it&rsquo;s up to $204.47 and is also still a strong buy. From its last traded price of $204.47, I&rsquo;d like to see it initially retest $260 near term. Better, about 25 analysts rate ZS as a buy with an average price target of $232.04.&nbsp;</p>



<p>Helping, the company&nbsp;just unveiled&nbsp;multiple innovations to its &ldquo;AI Data Protection Platform that leverage the world&rsquo;s largest security cloud and the power of AI,&rdquo;&nbsp;<a href="https://ir.zscaler.com/news-releases/news-release-details/zscaler-unveils-ai-innovations-power-industrys-most#:~:text=(NASDAQ%3A%20ZS)%2C%20the,most%20comprehensive%20data%20protection%20solution.">as noted by the company</a>.</p>



<p>That includes its &ldquo;&lsquo;Gen AI App Security&rsquo;, which offers context-rich user and risk correlation, providing insights into risky prompts, AI app usage and granular policy controls,&rdquo;&nbsp;<a href="https://technologymagazine.com/articles/how-zscaler-ai-innovation-is-powering-data-protection">says TechnologyMagazine.com</a>. &ldquo;This feature is crucial as the&nbsp;adoption of AI technologies continues to accelerate, presenting new security challenges.&rdquo;</p>



<h2><strong>CyberArk Software (CYBR)</strong></h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/cybr1600-300x169.jpg" alt="CyberArk stock"><div>Source: Shutterstock</div></div><p>&ldquo;I&rsquo;d also use weakness as an opportunity in&nbsp;<strong>CyberArk Software</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/cybr-stock-quote/"><strong>CYBR</strong></a>),&rdquo; I added on June 6. At the time, CYBR traded at about $225. Today, it&rsquo;s up to $275.31 and is still a buy. From $275.31, I&rsquo;d like to see it test $300 next.</p>



<p>Helping, <a href="https://www.tipranks.com/news/the-fly/cyberark-price-target-raised-to-315-from-280-at-barclays">analysts at Barclays just raised their price target on CYBR to $315</a> with an outperform rating. &ldquo;The analyst thinks security stocks have favorable setups into the Q2 earnings. Channel checks indicate enterprise security spending either held stable or improved moderately in Q2 versus Q1 for several security names,&rdquo; added TheFly.com.</p>



<p>Even better, <a href="https://www.tipranks.com/stocks/cybr/forecast">22 analysts have a buy rating</a> on the stock with an average price target of $299. The highest price target at the moment is $315, as set by Barclays.</p>



<p>Earnings have been solid. In its first quarter, the company posted earnings-per-share of 75 cents, which beat by 48 cents. Revenue of $221.6 million &ndash; up 37% year over year &ndash; beat by $8.38 million. The subscription portion of its annual recurring revenue jumped 54% to $621 million year over year. Total ARR jumped 69% to $156.2 million.</p>



<p><em>On the date of publication, Ian Cooper did not hold (either directly or indirectly) any positions in the securities mentioned. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/?utm_source=Nasdaq&amp;utm_medium=referral">Publishing Guidelines.</a></em></p>



<p><em>On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;</em></p>
<div><p>Ian Cooper, a contributor to InvestorPlace.com, has been analyzing stocks and options for web-based advisories since 1999.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/07/3-cybersecurity-stocks-that-could-be-multibaggers-in-the-making-july-edition/">3 Cybersecurity Stocks That Could Be Multibaggers in the Making: July Edition</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Cybersecurity Stocks That Could Be Multibaggers in the Making: July Edition

The latest update is out from Rite Aid (RADCQ). In August 2023, amid a potential restructuring transaction under bankruptcy proceedings, a company ...

Rite Aid Undertakes Financial Restructuring and Sells Elixir Business

Healthcare bankruptcies slow after peaking in 2023: report

Rite Aid exits bankruptcy; names new CEO

Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying

CVS Health strategic review brings segments into focus

AHPIQ

AKUMQ

ATHXQ

CANOQ

CYBR

DMTKQ

GMDAQ

HGENQ

LEVI

NVTAQ

PANW

RADCQ

SDCCQ

SRNE

UBER

VRAYQ

Press Releases

Rite Aid Becomes Copia's First Retail Pharmacy Partner to Help Combat Food Waste and Support Communities

Rite Aid Announces Availability of Opill at All Locations

Rite Aid Expands Partnership with Uber Eats to Deliver Alcohol in Additional Markets

Rite Aid and Bartell Drugs Host Monthly Immunization Days This Summer

Rite Aid Expands Partnership with Instacart to Offer EBT SNAP Online Payment Option from more than 1,400 Locations

Rite Aid Provides Notice of Security Incident

Rite Aid Announces Availability of Flu and RSV Vaccine Appointments at All Locations

Rite Aid and Bartell Drugs Announce Availability of Appointments for Updated COVID-19 Vaccine

Rite Aid Completes Restructuring Process and Emerges from Chapter 11

Rite Aid Corporation Names Matt Schroeder as Chief Executive Officer

CART

Comments

Rite Aid Corp

Notizie

Ultime notizie per Rite Aid Corp (OTC:RADCQ) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO